Approval · Notice of Compliance 5056 · 1995
COMBIVENT: Notice of Compliance 5056
Issued August 29, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5056
- Date
- August 29, 1995
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COMBIVENT | 02163721 | Cancelled Post Market |
Medicinal ingredients
- IPRATROPIUM BROMIDE 20 MCG per ACT
- SALBUTAMOL SULFATE 120 MCG per ACT